Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc. operates in the Medical - Equipment & Services industry of the Healthcare sector, headquartered in San Francisco, CA, US. The stock last traded at $29.44, down 3.51% on the session, giving a market capitalisation of $6.57B. On trailing twelve-month figures it carries a trailing P/E of -48.26, a net margin of -5.5%. Its beta of 2.40 implies it has historically moved more than the broad market.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
Hims & Hers Health, Inc. is most often compared with the following Healthcare names: